A new trading day began on Monday, with Applied Dna Sciences Inc (NASDAQ: APDN) stock price up 3.10% from the previous day of trading, before settling in for the closing price of $0.16. APDN’s price has ranged from $0.15 to $22.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 94.52%. Meanwhile, its annual earnings per share averaged 71.32%. With a float of $50.83 million, this company’s outstanding shares have now reached $50.90 million.
Let’s determine the extent of company efficiency that accounts for 55 employees. In terms of profitability, gross margin is 19.56%, operating margin of -439.2%, and the pretax margin is -217.48%.
Applied Dna Sciences Inc (APDN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Applied Dna Sciences Inc is 0.14%, while institutional ownership is 2.12%.
Applied Dna Sciences Inc (APDN) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -6.1 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.32% per share during the next fiscal year.
Applied Dna Sciences Inc (NASDAQ: APDN) Trading Performance Indicators
Here are Applied Dna Sciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.94, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.04 in one year’s time.
Technical Analysis of Applied Dna Sciences Inc (APDN)
Looking closely at Applied Dna Sciences Inc (NASDAQ: APDN), its last 5-days average volume was 2.53 million, which is a drop from its year-to-date volume of 3.73 million. As of the previous 9 days, the stock’s Stochastic %D was 27.39%. Additionally, its Average True Range was 0.04.
During the past 100 days, Applied Dna Sciences Inc’s (APDN) raw stochastic average was set at 0.40%, which indicates a significant decrease from 23.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.19% in the past 14 days, which was lower than the 252.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4244, while its 200-day Moving Average is $3.2109. However, in the short run, Applied Dna Sciences Inc’s stock first resistance to watch stands at $0.1666. Second resistance stands at $0.1735. The third major resistance level sits at $0.1784. If the price goes on to break the first support level at $0.1548, it is likely to go to the next support level at $0.1499. Now, if the price goes above the second support level, the third support stands at $0.1430.
Applied Dna Sciences Inc (NASDAQ: APDN) Key Stats
With a market capitalization of 7.96 million, the company has a total of 31,233K Shares Outstanding. Currently, annual sales are 13,370 K while annual income is -9,950 K. The company’s previous quarter sales were 800 K while its latest quarter income was 1,880 K.
